SCHEMBL25919180

SCHEMBL25919180

Cc1cc2ccccc2n1-c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.47
GSR P00390 1/20 0.46
SLC6A2 P23975 1/20 0.44
KMT2A Q03164 3/20 0.43
GRM1 Q13255 1/20 0.43
MAPT P10636 4/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
CYP2E1 P05181 2/20 0.42
CYP2A6 P11509 2/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 3/20 0.42
BLM P54132 1/20 0.42
PKM P14618 1/20 0.42
MDM2 Q00987 1/20 0.42
GFER P55789 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6847516 0.83 MDM2 (0.45) ALOX12KMT2AGRM1MAPTALDH1A1
SCHEMBL28062439 0.82 MAT2A (0.53) ALDH1A1KDM4ECYP3A4
SCHEMBL30446730 0.81 ALDH1A1 (0.55) SLC6A2KMT2AMAPTALDH1A1KDM4E
SCHEMBL1885602 0.81 ALDH1A1 (0.55) SLC6A2KMT2AMAPTALDH1A1KDM4E
SCHEMBL64405 0.79 ALDH1A1 (0.44) SLC6A2KMT2AMAPTALDH1A1KDM4E
SCHEMBL13425012 0.79 ALDH1A1 (0.47) SLC6A2KMT2AMAPTALDH1A1KDM4E
SCHEMBL13483671 0.79 TSHR (0.43) SLC6A2KMT2AMAPTALDH1A1KDM4E
SCHEMBL12091794 0.78 AOC3 (0.52) ALOX12KMT2AALDH1A1CYP3A4MDM2
SCHEMBL11000240 0.77 ALOX12 (0.41) ALOX12GSRKMT2AMAPTALDH1A1
SCHEMBL11005039 0.77 CYP19A1 (0.49) ALOX12GSRALDH1A1GFERNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242557-A9 PROTEASOME ACTIVITY ENHANCING COMPOUNDS Kineta, Inc. 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242557-A9 PROTEASOME ACTIVITY ENHANCING COMPOUNDS PSMG3, PSMB1, PSMC1 ALOX12 1828/4885GSR 986/4885SLC6A2 4835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.